title: [Clinical and experimental study on treating bronchial asthma with xingbei granule].
abstract: OBJECTIVE
  To explore the effect of the Xingbei Granule (XBG) in treating bronchial asthma and its mechanism.
  
  
  METHODS
  Systematic clinical observation and animal experimental study on the XBG were carried out.
  
  
  RESULTS
  The XBG not only could reduce the symptom of asthma, improve the ventilatory function effectively, but also has the effect of antagonizing the change of asthmatic inflammatory medium, alleviating the air-way's inflammatory reaction and lowering the air-way's hyperreactivity.
  
  
  CONCLUSIONS
  XBG do attain the dual goal of controlling the asthmatic symptoms and reducing the asthmatic attack.
authors.affiliation: Second Affilliated Hospital, Tianjin College of TCM, Tianjin.
authors.forename: Z T
authors.initials: ZT
authors.lastname: Sun
authors.forename: S X
authors.initials: SX
authors.lastname: Zhang
authors.forename: Y H
authors.initials: YH
authors.lastname: Tang
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000328:Adult; D000818:Animals; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000097:blood / Q000188:drug therapy*; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D008875:Middle Aged; D012129:Respiratory Function Tests; D013929:Thromboxane B2 / Q000097:blood
chemical_list: D018927:Anti-Asthmatic Agents; D004365:Drugs, Chinese Herbal; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha